| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Revenue | $4.36B | +4.5% |
| Cost of Revenue | $3.46B | +2.8% |
| Gross Profit | $898.2M | +11.9% |
| R&D Expense | $19.6M | -5.3% |
| SG&A Expense | $342.3M | +4.3% |
| Operating Income | $608.9M | +30.6% |
| Interest Expense | $124.2M | +17.4% |
| Pre-tax Income | $486.1M | +64.7% |
| Income Tax | $103.4M |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $721.2M | -3.1% |
| Accounts Receivable | $709.2M | +13.5% |
| Inventory | $1.35B | +8.5% |
| Current Assets | $2.94B | +7.6% |
| Total Assets | $5.23B | +4.9% |
| Current Liabilities | $1.21B | +23.7% |
| Long-term Debt | $1.71B | -20.2% |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $407.2M | +374.0% |
| Investing Cash Flow | -$159.6M | +17.4% |
| Financing Cash Flow | -$260.4M | -197.5% |
| +180.7% |
| Net Income | $367.8M | -10.5% |
| EPS (Basic) | $2.82 | -12.1% |
| EPS (Diluted) | $2.55 | -9.3% |
| Total Liabilities |
| $3.28B |
| -6.5% |
| Stockholders' Equity | $1.85B | +34.8% |